A Weibull multi-state model for the dependence of progression-free survival and overall survival.

about

Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.

P2860

Q47198852-29F5FD3F-8BA2-42A8-A60B-BC8FBA4054E2 Q50192034-983A538E-D7D8-456F-A7D6-A47EC7C56CCD

P2860

A Weibull multi-state model for the dependence of progression-free survival and overall survival.

Item

http://www.wikidata.org/entity/Q35812284

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Weibull multi-state model fo ...... survival and overall survival.

@ast

A Weibull multi-state model fo ...... survival and overall survival.

@en

type

Item

label

A Weibull multi-state model fo ...... survival and overall survival.

@ast

A Weibull multi-state model fo ...... survival and overall survival.

@en

prefLabel

A Weibull multi-state model fo ...... survival and overall survival.

@ast

A Weibull multi-state model fo ...... survival and overall survival.

@en

P1476

A Weibull multi-state model fo ...... survival and overall survival

@en

P2093

Qiang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design.

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

In the end what matters most? A review of clinical endpoints in advanced breast cancer.

Improving the design of phase II trials of cytostatic anticancer agents.

Progression-free survival as a surrogate endpoint in advanced breast cancer

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.

Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer.

Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments.

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

P304

2497-2513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SIM.6501

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yimei Li

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25865438

http://www.w3.org/2001/XMLSchema#string

P932

4490073

http://www.w3.org/2001/XMLSchema#string

A Weibull multi-state model for the dependence of progression-free survival and overall survival.

about

P2860

P2860

A Weibull multi-state model for the dependence of progression-free survival and overall survival.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932